Verso Biosense Limited is a medtech company founded in 2015 specializing in the research and development of innovative solutions for uterine health. Based in Milton Park, Abingdon, Oxfordshire, UK, the company focuses on a unique, integrated approach to understanding and addressing uterine conditions. Verso Biosense’s core technology centers around the IRIS smart intra-uterine sensors, a sophisticated wearable device and accompanying accessories designed for continuous monitoring of uterine health. The platform’s functionality includes real-time data collection and analysis, offering clinicians and patients valuable insights into uterine function. The company’s primary focus is on developing and validating a platform that facilitates early detection, personalized treatment, and improved patient outcomes related to uterine health. Verso Biosense operates as a limited company (Ltd) with a small team of skilled workers. The company’s international presence is currently non-existent, and hiring indicators are currently set to worker level. The company’s SIC codes encompass research and experimental development on natural sciences and engineering, specifically within the medical device and healthcare sectors. Verso Biosense’s activities are centered around improving the understanding of uterine conditions and their impact on uterine health.

Verso Biosense Limited is a medtech company founded in 2015 specializing in the research and development of innovative solutions for uterine health. Based in Milton Park, Abingdon, Oxfordshire, UK, the company focuses on a unique, integrated approach to understanding and addressing uterine conditions. Verso Biosense’s core technology centers around the IRIS smart intra-uterine sensors, a sophisticated wearable device and accompanying accessories designed for continuous monitoring of uterine health. The platform’s functionality includes real-time data collection and analysis, offering clinicians and patients valuable insights into uterine function. The company’s primary focus is on developing and validating a platform that facilitates early detection, personalized treatment, and improved patient outcomes related to uterine health. Verso Biosense operates as a limited company (Ltd) with a small team of skilled workers. The company’s international presence is currently non-existent, and hiring indicators are currently set to worker level. The company’s SIC codes encompass research and experimental development on natural sciences and engineering, specifically within the medical device and healthcare sectors. Verso Biosense’s activities are centered around improving the understanding of uterine conditions and their impact on uterine health.